HYTHIAM, INC. & E*TRADE FINANCIAL CORPORATION

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

Since the last Newsletter, we closed two more positions, one for a nice gain and one for a nasty loss.

MICROMET (4/20/08). Closed position 7/9/08 at $3.30 for a 65% GAIN.

VION PHARMA (5/20/05). Closed position 7/8/08 at $1.04 for a 96% LOSS. (price includes reverse split)

Ever since we picked Micromet in April, the stock pretty much went upward; then, in June, news of preclinical and Phase 2 starts on several of MITI’s drug candidates juiced the stock even more. Vion, which had been a huge disappointment, was closed for an expected ugly loss.

And so the market catharsis continues aided by high oil prices and persistent government meddling. Must we go on with this rant? Until there is a violent sell-off, the current lethargy will go on and go and on. Yes, we may see several days, or even a week, of bullishness in the market, but be careful, it is likely to be a head fake. We need the sell-off in order to get a better grasp of future entry points.

(more…)

APPLIED ENERGETICS, INC. & NEUROBIOLOGICAL TECHNOLOGIES, INC

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

Since the last Newsletter, we have closed three positions for gains and one for a nasty loss.

ENTRUST, INC. (2/20/08). Closed position 6/23/08 at $3.40 for a 51% GAIN.

BARRIER THERAPEUTICS (3/20/08). Closed position 6/23/08 at $4.10 for a 34% GAIN. (being acquired by Stiefel Labs)

KODIAK OIL & GAS. (9/5/07). Closed position 6/18/08 at $5.42 for a 53% GAIN.

02DIESEL (5/20/06). Closed position 6/18/08 at 15 cents for a 88% LOSS.

(more…)

AVIGEN, INC. & MMC ENERGY, INC.

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

About a week ago, CNBC’s Jim Cramer said it best, “This is an awful market”. That pretty much sums it up. As we have been harping, periodically, until the cataclysmic sell-off occurs, this death by a thousand knives will continue. The Fed and the Treasury have been preventing this with their socialism for Wall Street. Why do we want the blowout? It makes it easier to determine entry points. Currently, we are walking around in a very dimly-lit room. Take for example Dow component General Electric that was $35 a few months ago, and then $33 a few weeks ago. Both times, it seemed cheap. Presently, the stock is hovering around $30. Is this a good time to buy GE? One would think, but …?

And the same scenario spills over to our Current Portfolio. In almost every Newsletter for the last few months, we have said that this may be a good time to “bottom fish”, and we still think so. However, the fishing would be much easier if there was less water in the pond.

(more…)

ENERGY FOCUS, INC. & BRIDGELINE SOFTWARE, INC.

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

Since the last Newsletter, we closed two more positions, one for a very nice gain and another for an ugly loss:

Kosan Biosciences (5/5/08). Closed position 5/29/08 at $5.43 for a 227% GAIN.

Aviza Technology (10/5/04). Closed position 5/28/08 at 53 cents for a 92% LOSS.

Never in our twelve years of publishing this Newsletter have we ever had two picks be acquired for such huge gains within three weeks of one another. Earlier in May, Iomai was acquired by Intercell, and then, at the end of the month, Kosan was bought out by Bristol-MyersSquibb for $5.50 a share. And this happened in a very crummy market. We closed Aviza for a long expected loss.

The good news is the cataclysmic sell-off that we have been expecting hasn’t yet occurred. That’s also the bad news, as we have periodically mentioned over the last few months. No, we are not hoping for doomsday, but the market needs a new base, or reference points of true value. The credit crunch and soaring energy costs still have not been factored into most stock prices and, until that happens, the markets, as well as our own Current Portfolio, will keep floundering and flapping in its current sideways pattern. Of course, every time the market is prepared to atomize the Fed/government steps in to prop things up, and this has become a new and unfamiliar problem. Waiting is tough and bottom fishing can be maddening, but, for now, the operative word is patience.

(more…)

MICROVISION, INC. & GLOBALSCAPE, INC.

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

Since the last Newsletter, we have closed five positions; three for gains and two for losses.

IOMAI CORPORATION (8/20/07). Closed position 5/13/08 at $6.30 for a 260% GAIN.

NETSOL TECHNOLOGIES (3/5/08). Closed position 5/13/08 at $3.02 for a 54% GAIN.

GSI TECHNOLOGY (2/5/08). Closed position 5/12/08 at $4.40 for a 76% GAIN.

OPEN TV (3/20/04). Closed position 5/12/08 at $1.62 for a 42% LOSS.

PALATIN (4/5/04). Closed position 5/12/08 at 27 cents for a 93% LOSS.

(more…)

KOSAN BIOSCIENCES, INC. & ZIOPHARM ONCOLOGY, INC.

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

It has now been at least six months since we started joining the gloom and doom crowd, and, frankly, because of the Fed flooding the universe with funny money, we thought that soon a light would appear at the end of the black hole. Then, an eerie thing happened on the way to the hoped-for recovery. Energy and commodity prices have soared because of the Fed’s rush to bail out the wealthy; a few Newsletters ago, we called it welfare for Wall Street, or something along those lines. The best thing the Fed can now do is to do simply nothing and let the markets finally run their course. The more they interfere, the longer the pain continues. We would have preferred to have seen a cataclysmic sell-off because that would have signaled the end to the catharsis. We are navigating unchartered waters, but the bottom-fishing could be good.

(more…)

MICROMET, INC. & KOPIN CORPORATION

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

Since the last Newsletter, we closed another position, for a nice gain.

BOOTS & COOTS (9/20/07). Closed position 4/8/08 at $1.92 for a 60% GAIN.

Ever since we picked it, Boots & Coots stock has made steady upside progress and then probably got a nice push due to a upbeat research report from RedChip. Yes, WEL could possibly go higher, but, for now, we’ll take the small victories and the 60% gain.

Looks as if the end-of-March early-April gave us the classic rally in a bear market, a/k/a a head-fake. The positive was that at least there was a rally, proof of alien life forms. During the last five to seven months, we have been very negative on the markets, as most of you know, however, we cannot help but feel that we are nearing the end of the carnage. Yes, there will be more pain because earnings reports will be less than rosy, and let’s not forget about the credit crisis, which will continue for some time, but, as we said in the last Newsletter, the Fed has our backs. Overall, our Current Portfolio is still stagnant, but there are now a few signs of breathing. And yes, the operative phrase is still “bottom fish”.

(more…)

REPLIDYNE, INC. & BIOLASE TECHNOLOGY, INC.

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

Since the last Newsletter we closed two positions, one for a nice gain and two for losses.

NEUROGEN (2/5/08). Closed position 3/20/08 at $3.40 for a 70% GAIN.

WJ COMMUNICATIONS (12/5/06). Closed position 3/20/08 at 95 cents for a 52% LOSS.

CYTOGEN (3/20/06). Closed position 3/20/08 at 57 cents for a 83% LOSS. At the time we closed it, we had no clue as to why Neurogen soared almost $1.25 in a day, and, in this market, why ask questions; someone knew something or thought they did. The deal between TriQuint and WJ Communications looks as if it will go through at $1.00 a share, so, why hang around for the extra nickel? Ditto for Cytogen, which is being bought by EUSA Pharma.

Once again, our Current Portfolio remains pretty much the same as it did several weeks ago, and several months ago. As we said in the last Newsletter, the more that the Fed and the government “help” things the more prolonged will be the pain. Actually, if one looks closely, both in appearance and in recent actions, George Bush is transforming into LBJ and Ben Bernanke is resembling Lenin. We now have nearly complete socialism of the markets. The rich masses have been saved from themselves! The best thing the Fed/Treasury could do is to allow the other types of Bear Stearns to fold; after all, they abetted this mess. Then, instead of lower interest rates, which are near zero once again, rates should be raised and that move would strengthen the dollar and maybe ease commodity prices.

So, we continue to say “bottom fish”, but, remember, think long-term. The Fed has your back.

(more…)

RODMAN & RENSHAW CAPITAL GROUP, INC. & BARRIER THERAPEUTICS, INC.

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

Back in January, we said that our Current Portfolio was the worst it has ever looked and that the markets were the ugliest we have seen since the 1980s. Scratch that. This is now the worse and the ugliest. Yes, the Fed is acting to improve the liquidity situation, a situation that it helped to create, but there is now much shattered confidence, nose-bleed high oil prices, and, boy, aren’t we all excited about the next President! As we alluded in the last Newsletter, it would probably be better to let the markets capitulate rather than to have this death by a thousand knives. Sure, the Treasury, the Fed, and other regulators/agencies/whatever mean well, but their current actions are just delaying, or dragging out, the recession, thereby making things worse.

Now despite this rosy picture we just painted, we still feel that some ‘bottom fishing’ may be in order. Just don’t bait the rod with overly expensive flies and have some patience.

Here are the headlines since the last Newsletter about companies in the Current Portfolio. Dates in parentheses are when we first recommended them.

(more…)

NETSOL TECHNOLOGIES, INC. & ACTIVIDENTITY CORPORATION

***We no longer follow the companies mentioned in these backdated newsletter issues. These samples of past newsletters are generated to give you an idea of what you can expect when you subscribe. Please do not use any of the information contained in the samples below as current advice. If you would like to purchase a newsletter subscription, please click here. ***

Hello Readers,

Thanks to the February 29 nosedive, the markets are pretty much at the same place they were a few weeks ago, which, for some, is considered a mini-triumph. We would have preferred a major sell-off, the kind that leaves us breathing into a paper bag. We could have finally said the bottom is here and that we are officially in a recession (psssst, we really are). Then, the only guesswork would have been when does the market begin its rebound. Instead, we must endure more waterboarding while the geniuses figure out what to screw up next. Where is J.P. Morgan? Remember 1907?

Overall, our Current Portfolio looks about the same as it did in mid-February, which isn’t good; but, as we have been saying for the last few months, it’s going to take a while to repair all of the damage. And, yes, we still feel this may be a good time to go bottom fishing.

Here are the headlines since the last Newsletter about companies in our Current Portfolio. Dates in parentheses are when we first recommended them.

(more…)